Series B

CellTivity Scientific's Van Gogh system hits a major milestone, proving that real-time metabolic imaging is shifting from a niche tool to a surgical standard.

North.cloud’s $60 million Series B signals a fundamental shift in enterprise tech: the transition from passive cloud observability to agentic financial control.

Salience Labs just secured $125 million from fierce rivals AMD and Intel to replace bottlenecked datacenter networks with silicon photonics.

GENISOM AI’s latest quadruped robots and a massive UAE-backed funding round signal a geopolitical and technological shift in how we build and deploy AI.

A Carnegie Mellon spinout just secured $97 million to scale its radically efficient chip architecture from edge robotics to power-hungry data centers.

Armed with $33 million in Series B funding, the microbiome data platform is building a B2B clinical infrastructure to power precision medicine.

As synthetic identities and remote work scams surge, Yardstik's latest board appointment signals the end of the one-time background check.

By replacing rare-earth metals with smart software, Tau Motors is forging a more resilient, equitable path for global electrification and clean energy.

Chemify secures £22M in grants and extends its Series B to £51.9M to build automated 'Chemifarms,' transforming chemical synthesis into executable code.

While chatbots write poems, a new 'Physical AI' is quietly optimizing the real world. A major funding round for DeepCtrls reveals AI's next, tangible act.

Miami's DermaSensor lands $5M and four major US partnerships, setting the stage to rapidly scale its FDA-cleared AI skin cancer detection device nationwide.

With a $70M boost and backing from Eli Lilly, Moonwalk Biosciences aims to redefine obesity treatment by targeting fat tissue directly, not appetite.

Medici Brands just raised $250M, but the story isn't the money. It's the hidden tech platform, built on a proprietary fat substitute, that's upending CPG.

As AI pushes traditional networks to their breaking point, a Valencia-based startup lands a huge Series B to commercialize its programmable optical switches.

A Santa Clara startup just secured $30M from a single investor. Their goal: use AI to fix a critical bottleneck that slows down all of tech.

With a fresh $20M, Standard Metrics is arming VCs with AI. We dig into whether its platform is just another tool or a true revolution in transparency.

The custom rug disruptor just raised $20M. But its real power play lies in a new NYC HQ and key hires from Peloton, revealing a strategy to own the market.

AI video platform Higgsfield raises $400M at a $5.4B valuation, hitting $700M in revenue as it aims to reshape the multi-trillion-dollar media market.

Fortress Biotech's Q2 net loss masks a cash-rich strategy. A $117M cash surge and major pipeline wins reveal a model built for the long haul.

With a massive Series B and the launch of a Phase 3 study, Vaderis Therapeutics is poised to deliver the first-ever approved therapy for a long-neglected rare disease.